Cite
HARVARD Citation
, . et al. (2017). Real-World Efficacy and Safety of Ritonavir-Boosted Paritaprevir, Ombitasvir, Dasabuvir ± Ribavirin for Hepatitis C Genotype 1 – Final Results of the REV1TAL Study. Antiviral therapy. 22 (8), pp. 699-710. [Online].